CRISPR Human Knockout Screens Identify New Target for ALS – Genetic Engineering & Biotechnology News
|
CRISPR Human Knockout Screens Identify New Target for ALS
Genetic Engineering & Biotechnology News A team at Stanford University School of Medicine has used CRISPR/Cas9 technology to gain new insights into the genes that might represent new targets for the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Led by Aaron Gitler, Ph.D … |
